Literature DB >> 17008320

Removal of pattern-breaking sequences in microtubule binding repeats produces instantaneous tau aggregation and toxicity.

Asparouh Iliev Iliev1, Sundar Ganesan, Gertrude Bunt, Fred Silvester Wouters.   

Abstract

Aggregated and highly phosphorylated tau protein is a pathological hallmark of Alzheimer's disease (AD) and other tauopathies. We identified motifs of alternating polar and apolar amino acids within the microtubule-binding repeats of tau which were interrupted by small breaking stretches. Minimal mutation of these breaking sequences yielded a unique instantly aggregating tau mutant containing longer stretches of polar/apolar amino acids without losing its microtubule-binding capacity. These modifications produced rapid aggregation and cytotoxicity with accompanying occurrence of pathologic tau phosphoepitopes (AT8, AT180, AT270, AT100, Ser(422), and PHF-1) and conformational epitopes (MC-1 and Alz50) in cells. Similar to pathological tau in the pretangle state, toxicity appeared to occur early without the requirement for extensive fibril formation. Thus, our mutant protein provides a novel platform for the investigation of the molecular mechanisms for toxicity and cellular behavior of pathologically aggregated tau proteins and the identification of its interaction partners.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17008320     DOI: 10.1074/jbc.M604863200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Resolution doubling in fluorescence microscopy with confocal spinning-disk image scanning microscopy.

Authors:  Olaf Schulz; Christoph Pieper; Michaela Clever; Janine Pfaff; Aike Ruhlandt; Ralph H Kehlenbach; Fred S Wouters; Jörg Großhans; Gertrude Bunt; Jörg Enderlein
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-09       Impact factor: 11.205

2.  Propagation of tau pathology in a model of early Alzheimer's disease.

Authors:  Alix de Calignon; Manuela Polydoro; Marc Suárez-Calvet; Christopher William; David H Adamowicz; Kathy J Kopeikina; Rose Pitstick; Naruhiko Sahara; Karen H Ashe; George A Carlson; Tara L Spires-Jones; Bradley T Hyman
Journal:  Neuron       Date:  2012-02-23       Impact factor: 17.173

3.  Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo.

Authors:  Erin E Congdon; Jessica W Wu; Natura Myeku; Yvette H Figueroa; Mathieu Herman; Paul S Marinec; Jason E Gestwicki; Chad A Dickey; W Haung Yu; Karen E Duff
Journal:  Autophagy       Date:  2012-04-01       Impact factor: 16.016

4.  Multiple mechanisms of extracellular tau spreading in a non-transgenic tauopathy model.

Authors:  Meghan N Le; Wonhee Kim; Sangmook Lee; Ann C McKee; Garth F Hall
Journal:  Am J Neurodegener Dis       Date:  2012-11-25

5.  Gene Therapy Models of Alzheimer's Disease and Other Dementias.

Authors:  Benjamin Combs; Andrew Kneynsberg; Nicholas M Kanaan
Journal:  Methods Mol Biol       Date:  2016

Review 6.  Is tau ready for admission to the prion club?

Authors:  Garth F Hall; Brian A Patuto
Journal:  Prion       Date:  2012-07-01       Impact factor: 3.931

7.  Widespread protein aggregation as an inherent part of aging in C. elegans.

Authors:  Della C David; Noah Ollikainen; Jonathan C Trinidad; Michael P Cary; Alma L Burlingame; Cynthia Kenyon
Journal:  PLoS Biol       Date:  2010-08-10       Impact factor: 8.029

8.  Two-dimensional electrophoresis of tau mutants reveals specific phosphorylation pattern likely linked to early tau conformational changes.

Authors:  Alexis Bretteville; Kunie Ando; Antoine Ghestem; Anne Loyens; Séverine Bégard; Jean-Claude Beauvillain; Nicolas Sergeant; Malika Hamdane; Luc Buée
Journal:  PLoS One       Date:  2009-03-17       Impact factor: 3.240

9.  Caspase-mediated truncation of tau potentiates aggregation.

Authors:  Sangmook Lee; Thomas B Shea
Journal:  Int J Alzheimers Dis       Date:  2012-09-04

10.  Tau pathology is present in vivo and develops in vitro in sensory neurons from human P301S tau transgenic mice: a system for screening drugs against tauopathies.

Authors:  Manuela Mellone; Dimitra Kestoras; Melissa R Andrews; Elisa Dassie; R Anthony Crowther; Gorazd B Stokin; Jon Tinsley; Graeme Horne; Michel Goedert; Aviva M Tolkovsky; Maria Grazia Spillantini
Journal:  J Neurosci       Date:  2013-11-13       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.